Abstract
A target-based approach has been used to develop novel drugs in many therapeutic fields. However, this approach remains suboptimal for drug discovery in brain disorders because the target identification in a brain disorder requires a hierarchical integration from in vitro cellular and functional tissue studies to animal models that sustain neuronal and glial complexity. Although glial cells comprise over half of the brain and play important roles in brain function and disease, the intracellular signaling of glial cells remains essentially unexplored. This is because the lack of optimal strategy to selectively activate or deactivate glial signaling has made it difficult to study glial roles. The recent development of approaches using mouse models and enabling the selective activation of cell signaling could be used to assess the role of glial cells in physiology and disease. This review presents how glial G- protein signaling contributes to brain disorders and how the role of glia is investigated.
Keywords: Gq-DREADD (designer receptor exclusively activated by designer drug), glial cells, G-protein coupled receptors, proteomics, neuronal disorder, tissue culture.
CNS & Neurological Disorders - Drug Targets
Title:Recent Approaches for Studying the Role of Glia
Volume: 13 Issue: 1
Author(s): Seyeon Park
Affiliation:
Keywords: Gq-DREADD (designer receptor exclusively activated by designer drug), glial cells, G-protein coupled receptors, proteomics, neuronal disorder, tissue culture.
Abstract: A target-based approach has been used to develop novel drugs in many therapeutic fields. However, this approach remains suboptimal for drug discovery in brain disorders because the target identification in a brain disorder requires a hierarchical integration from in vitro cellular and functional tissue studies to animal models that sustain neuronal and glial complexity. Although glial cells comprise over half of the brain and play important roles in brain function and disease, the intracellular signaling of glial cells remains essentially unexplored. This is because the lack of optimal strategy to selectively activate or deactivate glial signaling has made it difficult to study glial roles. The recent development of approaches using mouse models and enabling the selective activation of cell signaling could be used to assess the role of glial cells in physiology and disease. This review presents how glial G- protein signaling contributes to brain disorders and how the role of glia is investigated.
Export Options
About this article
Cite this article as:
Park Seyeon, Recent Approaches for Studying the Role of Glia, CNS & Neurological Disorders - Drug Targets 2014; 13 (1) . https://dx.doi.org/10.2174/18715273113126660191
DOI https://dx.doi.org/10.2174/18715273113126660191 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Zinc, Metallothioneins and Longevity: Interrelationships with Niacin and Selenium
Current Pharmaceutical Design Tumor-Receptor Imaging in Breast Cancer: A Tool for Patient Selection and Response Monitoring
Current Molecular Medicine Angiogenesis and Angiogenesis Inhibitors: a New Potential Anticancer Therapeutic Strategy
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Targeting Microtubules to Inhibit Angiogenesis and Disrupt Tumour Vasculature:Implications for Cancer Treatment
Current Cancer Drug Targets Nanomaterial Based Approaches for the Diagnosis and Therapy of Cardiovascular Diseases
Current Pharmaceutical Design Angiotensin II Receptor Blocker: Possibility of Antitumor Agent for Prostate Cancer
Mini-Reviews in Medicinal Chemistry Mesenchymal Stem/Stromal Cells: A New "Cells as Drugs" Paradigm. Efficacy and Critical Aspects in Cell Therapy
Current Pharmaceutical Design Clinical Importance and Potential Use of Small Molecule Inhibitors of Focal Adhesion Kinase
Anti-Cancer Agents in Medicinal Chemistry Histone Deacetylases: Anti-Angiogenic Targets in Cancer Therapy
Current Cancer Drug Targets Ribonucleases and ImmunoRNases as Anticancer Drugs
Current Pharmaceutical Design HSV Amplicon Vectors for Cancer Therapy
Current Gene Therapy Propolis Extract Regulates microRNA Expression in Glioblastoma and Brain Cancer Stem Cells
Anti-Cancer Agents in Medicinal Chemistry Magnetic Resonance Diffusion Tensor Imaging and Diffusion Tensor Tractography in the Evaluation of Congenital and Acquired Diseases of the Pediatric Visual System
Current Pediatric Reviews Automated PET Radiotracer Manufacture on the BG75 System and Imaging Validation Studies of [18F]fluoromisonidazole ([18F]FMISO)
Current Radiopharmaceuticals Discovery of Potent Natural-Product-Derived SIRT2 Inhibitors Using Structure- Based Exploration of SIRT2 Pharmacophoric Space Coupled With QSAR Analyses
Anti-Cancer Agents in Medicinal Chemistry HSP90 Inhibitors: Multi-Targeted Antitumor Effects and Novel Combinatorial Therapeutic Approaches in Cancer Therapy
Current Medicinal Chemistry SPARC in Tumor Pathophysiology and as a Potential Therapeutic Target
Current Pharmaceutical Design Aneurysm of the Communicating Vein Between the Left Renal Vein and Left Ascending Lumbar Vein Mimicking Retroperitoneal Lymphadenopathy: A Case Report
Current Medical Imaging Biochemistry and Biology of 2'-Fluoro-2'-Deoxythymidine (FT), A Putative Highly Selective Substrate for Thymidine Kinase Type 2 (TK2)
Current Radiopharmaceuticals A Review of the ADAMTS Family, Pharmaceutical Targets of the Future
Current Pharmaceutical Design